HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12‐month deferral policy for men who have sex with men-Reference-Cited by-同舟云学术

HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12‐month deferral policy for men who have sex with men

Published:2021-01-18 Issue:3 Volume:61 Page:839-850
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Steele Whitney R.¹^ORCID,Dodd Roger Y.¹,Notari Edward P.¹,Haynes James¹,Anderson Steven A.²,Williams Alan E.²,Reik Rita³,Kessler Debra⁴,Custer Brian⁵^ORCID,Stramer Susan L.¹^ORCID,

Affiliation:

1. American Red Cross Gaithersburg Maryland USA

2. U.S. Food and Drug Administration Silver Spring Maryland USA

3. OneBlood St. Petersburg Florida USA

4. New York Blood Center New York New York USA

5. Vitalant Research Institute San Francisco California USA

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.16250

Reference18 articles.

1. US Food and Drug Administration.Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products‐Guidance for Industry 2015: (Revised 2020 see Notice of Availability 80 FR 79913 (December 17 2015).

2. Transfusion-transmissible infection monitoring system: a tool to monitor changes in blood safety

3. Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms

4. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing

5. HIV incidence in US first-time blood donors and transfusion risk with a 12-month deferral for men who have sex with men

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementing pathogen reduction technology while discontinuing blood donor deferral criteria for sexual risk behaviors: A simulation study;Transfusion;2024-08-10

2. Insight into hazards and control of transfusion-transmitted infections in Egypt: A narrative review;Transfusion and Apheresis Science;2024-08

3. Blood safety markers in Dutch donors after relaxation of deferral for men who have sex with men: re‐emergence of syphilis and HIV pre‐exposure prophylaxis use;Transfusion;2024-07-04

4. HIV Subtypes and Drug-resistance-associated Mutations in US Blood Donors, 2015–2020;Open Forum Infectious Diseases;2024-06-17

5. Modeling US blood donor deferrals under a policy of individual risk assessment for HIV risk sexual behavior;Transfusion;2024-06-12